Hepatitis: all 3,372 studies
Page 14 of 34. Open to participants first (195), then studies with results posted, then the rest; newest registration first within each.
- TDF Combined With LDT for the Treatment of HBeAg-positive Hepatitis B Patients With Poor Response to TDF for 12 MonthsStatus unknownNCT04650828
- Study of Entecavir for Reducing the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B PatientsStatus unknownNCT04646928
- LDT Combined With TDF to Improve EGFR Decreasing in Patients With Chronic Hepatitis B Treated With TDFStatus unknownNCT04643990
- A Study to Evaluate the Mass Balance Absorption and AME of VBRCompletedNCT04637139Phase 1
- Activity of NCO-48 Fumarate in Treatment-Naive Adults With Chronic Hepatitis BCompletedNCT04629976Phase 1
- HCV Treatment Initiation During Acute Psychiatric AdmissionStatus unknownNCT04625322Phase 4
- Single Patient Protocol for Donor HCV-positive to Recipient HCV-negative Kidney Transplant in a Patient at Risk for Loss of Dialysis AccessWithdrawnNCT04614142Phase 4
- HCV RNA Fingerstick Assay as Useful Point of Care of Diagnostic Tool for Drug Users in BrusselsCompletedNCT04610762
- Study on the Prevalence of Hepatitis C In a psychiatRic PopulationCompletedNCT04600479Not applicable
- Prevention of Transmission of Hepatitis C Virus (HCV) From HCV-Viremic Organ DonorCompletedNCT04596475Phase 1/2
- HCV Epidemiological Survey in China Rural AreaCompletedNCT04593355
- Clinical Trials to Compare the Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 DiabetesStatus unknownNCT04584242Phase 4
- Clinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD.CompletedNCT04579874Not applicable
- Study of Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12 Years or Older With Chronic Hepatitis C to Assess Sustained Virological ResponseCompletedNCT04577482
- Study on Antiviral Therapy for HBeAg-positive Chronic Hepatitis B Patients Aged 1-16 YearsStatus unknownNCT04565262Phase 4
- A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 TreatmentCompletedNCT04563026Phase 2
- Leptin and Liver Enzymes Responses to Aerobic Training in Hepatitis c PatientsStatus unknownNCT04550273Not applicable
- HepATocellular Cancer Hcv Therapy StudyWithdrawnNCT04546802Phase 3
- Changes in gUt micRobiota After Enteral Feeding (in Alcoholic Hepatitis)CompletedNCT04544020
- Endoscopic and Microbiological Assessment of the Effect of Carvedilol Combined With Berberine on GOV in CirrhosisStatus unknownNCT04543643Phase 3
- Pradefovir Treatment for the Patients With Chronic Hepatitis B Virus Infections: a Phase3 StudyStatus unknownNCT04543565Phase 3
- Immunogenicity of the Hepatitis B VaccineStatus unknownNCT04540653Phase 4
- Clinical Trial to Evaluate the Efficacy and Safety of TenofoBell® Tablet in Chronic Hepatitis B PatientsCompletedNCT04539652Phase 4
- A Cross-sectional Study for Renal Function of Patients With Chronic Hepatitis B in ChinaStatus unknownNCT04538651
- Evaluation HEC121120 Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of StudyTerminatedNCT04536532Phase 1/2
- Improving Inpatient Screening for Hepatitis CCompletedNCT04525690Not applicable
- Plasma Purification and Chronic Hepatitis BStatus unknownNCT04518553Not applicable
- Link Hepatitis C Notifications to Treatment in TasmaniaStatus unknownNCT04510246Not applicable
- Efficacy and Safety of TAF in Pregnant Women With Chronic Hepatitis B InfectionStatus unknownNCT04507607Early Phase 1
- Healthy Planet Hepatitis BCompletedNCT04503993Not applicable
- The Efficacy and Safety of TAF vs Other NAs in Patients With LVLStatus unknownNCT04501224Not applicable
- Testing of a Navigation Intervention for Hepatitis C and HIVTerminatedNCT04499651Not applicable
- A Study of ALG-010133 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB SubjectsTerminatedNCT04485663Phase 1
- Epidemiological Survey of Hepatitis D Virus Infection in ChinaCompletedNCT04483518
- A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of Oral HRS5091 in Healthy Subjects and Chronic Hepatitis B PatientsStatus unknownNCT04480294Phase 1
- A Study of EDP-514 in Patients With Chronic Hepatitis B Virus Infection Who Are Not Currently on TreatmentCompletedNCT04470388Phase 1
- Re-linkage to Care of Patients With Hepatitis CStatus unknownNCT04470271
- A Phase II Study of Subcutaneously Injected PD-L1 Antibody ASC22 in Chronic Hepatitis B PatientsCompletedNCT04465890Phase 2
- Safety, Tolerability, Pharmacokinetics(PK), Pharmacodynamics(PD) and Food Effect of HRS9950 in Healthy and CHB SubjectsCompletedNCT04464733Phase 1
- Lyon Granulomatous Hepatitis StudyStatus unknownNCT04459897
- Effect of Hepatitis C Clearance on Insulin ResistanceCompletedNCT04457050Phase 4
- HBV Vaccine in Anti-core Positive Donors After LTStatus unknownNCT04442841Phase 2
- Screening for Chronic Hepatitis C Virus in Hospitalized PatientsCompletedNCT04437277Not applicable
- A Trial to Assess the Effect of an Intervention Integrating Contingency Management (Financial Incentives) to Enhance Hepatitis C Treatment Uptake Following Dried Blood Spot Hepatitis C RNA Testing Among People With Recent Injecting Drug Use Attending Needle and Syringe ProgramsStatus unknownNCT04428346Not applicable
- A Phase II Study of Hepalatide in Subjects With Chronic Hepatitis BCompletedNCT04426968Phase 2
- STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention for Elevated LFTsWithdrawnNCT04395118Not applicable
- Sofosbuvir/Ombitasvir/Paritaprevir/ Ritonavir and Ribavirin for Hepatitis C Virus Genotype 4 PatientsCompletedNCT04391985Phase 1/2
- Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology As ReferenceCompletedNCT04389593
- P300 in Early Cognitive Impairment in Hepatitis C VirusCompletedNCT04389268
- Sofosbuvir Plus Daclatasvir With or Without Ribavirin and Chronic HCV Genotype (GT) 4CompletedNCT04387526Phase 2/3
- Use of Dynavax Heplisav B in Healthcare Workers Previously Vaccinated With 3-dose Vaccine Who Failed to Demonstrate SeroprotectionWithdrawnNCT04385524Not applicable
- Sofosbuvir With Ribavirin or Simeprevir With HCV GT4 Egyptian PatientsCompletedNCT04385407Phase 2
- Sofosbuvir/Pegylated-interferon Plus Ribavirin With HCV Genotype 4CompletedNCT04382339Phase 1/2
- Ombitasvir /Paritaprevir/Ritonavir Plus Ribavirin on HCV GT4CompletedNCT04378608Phase 1/2
- Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard TherapyStatus unknownNCT04376528Phase 4
- Effect of JKB-122 on Prednisolone and Azathioprine Induced Remission in Autoimmune Hepatitis (AIH)Status unknownNCT04371718Phase 2
- Seroepidemiology of Viral Hepatitis in Hong KongCompletedNCT04371276
- A Study Describing the Care Cascade and Effectiveness and Safety of Glecaprevir/Pibrentasvir in Adult Participants With Hepatitis C Virus in French Addiction CentersCompletedNCT04366973
- HBV/HCV/HIV in Belgian PrisonsCompletedNCT04366492Not applicable
- A Study of the Oral Farnesoid X Receptor Modulator EYP001a to Assess Its Safety and Anti-viral Effect in Chronic Hepatitis B Patients in Combination With Pegylated Interferon alpha2a Alone and With EntecavirCompletedNCT04365933Phase 2
- Reaching Out to the UNdiagnosed People Infected With Blood Borne Viral InfectionsCompletedNCT04363411Not applicable
- Risk of Hepatitis Flare in Patients With Previous Hepatitis B Virus Exposure Amongst PatientsTerminatedNCT04356404
- Efficacy Study Of Oral Glecaprevir/Pibrentasvir Tablet In Pediatric (12 Years and Older) And Adult Treatment-Naive Participants With Chronic Hepatitis C Genotypes 1 To 6 And Liver CirrhosisCompletedNCT04352309
- AIH Risk Stratification With Multiparametric MRITerminatedNCT04339621
- Effects of Direct-acting Antiviral Agents on HCV Cognitive Function, and Depression in HCV Related Cirrhosis: A Prospective Clinical TrialCompletedNCT04330508
- Hepatitis B en Haitian Immigrants in Chile: Molecular Characterization and Determination of Vaccine ResponseStatus unknownNCT04326803Phase 4
- Pharmacist-led Hepatitis C ManagementStatus unknownNCT04322981Phase 4
- HCV + to HCV - Kidney TransplantWithdrawnNCT04320290Phase 4
- Therapeutic Hepatitis C Virus VaccineStatus unknownNCT04318379Phase 1
- DBS Evaluation of Fujirebio INNOTEST® HCV Ab IVCompletedNCT04317729Not applicable
- "Cocktail" Therapy for Hepatitis B Related Hepatocellular CarcinomaStatus unknownNCT04317248Phase 2
- Study of AT-777 in Healthy Subjects and AT-777 in Combination With AT-527 in HCV-Infected SubjectsWithdrawnNCT04309734Phase 1/2
- Genomic Resources for Enhancing Available Therapies (GREAT1.0) StudySuspendedNCT04306939
- A Cohort Study on Long-term Clinical Outcomes of Antiviral Therapy in Patients With Chronic Hepatitis B and CirrhosisStatus unknownNCT04301908
- An Observational Cohort Study of Clinical Outcomes After Antiviral Treatment of Chronic Hepatitis CStatus unknownNCT04301882
- A Study to Evaluate the Efficacy and Safety of Therapeutic Hepatitis B VaccineCompletedNCT04289987Phase 2
- Evaluation of Novel Point of Care Hepatitis B Diagnostic AssaysWithdrawnNCT04289428
- Metabolic Surgery for Steato-HepatitisStatus unknownNCT04282005Not applicable
- Baseline Investigation of Chronic Hepatitis B Viruses Infections: Who is Eligible for Treated CriteriaCompletedNCT04264312
- HCV Reinfection After DAA Therapy in PWID in BelgiumStatus unknownNCT04251572Not applicable
- A Phase 1 Double-Blinded Study for Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ATI-2173 in Healthy Subjects and Subjects With Chronic Hepatitis B Virus InfectionCompletedNCT04248426Phase 1
- Autoimmune Hepatitis in Pediatric PatientsCompletedNCT04247490
- Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Sofosbuvir in Treatment-naïve Patients With Chronic Hepatitis C Genotype 1CompletedNCT04246723Phase 2
- VIRal Hepatitis and GAllstone Disease StudySuspendedNCT04222803
- Opportunstic Hepatitis C Virus TreatmentCompletedNCT04220645Not applicable
- Metabolic Changes in Chronic HCV Patients Receiving DAASStatus unknownNCT04211844
- Maternal Therapy With TAF Versus TDF to Prevent Vertical Transmission of Hepatitis BStatus unknownNCT04211805
- Hepatitis C Elimination in the NetherlandsStatus unknownNCT04208035
- Abatacept for Treatment of Recurrent or de Novo Autoimmune HepatitisTerminatedNCT04203875Phase 1
- Switching From Tenofovir Disoproxil Fumarate to Besifovir Dipivoxil MaleateStatus unknownNCT04202536Phase 4
- Voices From the Black Community: Hepatitis C Research ParticipationCompletedNCT04202081
- Efficacy and Safety of TAF in Patients With Suboptimal Response to Other Nucleos(t)IdesStatus unknownNCT04201808Phase 4
- The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC74647 in HCV-infected SubjectsCompletedNCT04201275Phase 1
- Detecting Occult HBV Infection in Liver Donors Positive for Antibody to Hepatitis B Core Antigen (Anti-HBc)Status unknownNCT04199819Not applicable
- Safety and Efficacy of a Hepatitis B Vaccine in Immunosuppressed PatientsCompletedNCT04199715Phase 1
- Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Hepatitis b Virus Related Compensated CirrhosisStatus unknownNCT04196998Not applicable
- RL-1 Novel Human-derived Bio-artificial Liver Treatment in Patients of HBV Related ACLFStatus unknownNCT04195282Not applicable
- Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Chronic Hepatitis bStatus unknownNCT04195074Not applicable
- GastrOesophageal Varices After Sustained Virological ResponseStatus unknownNCT04191018
- Sleep Apnoea Syndrome and Hepatocellular CarcinomaWithdrawnNCT04190498